cobas® SARS-CoV-2 & Influenza A/B
By Roche Diagnostics · Switzerland

Summary
cobas® SARS-CoV-2 & Influenza A/B is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Stated instrument compatibility: cobas® liat. Registration status and availability vary by market.
Classification
- Category
- Molecular Assays
- Subcategory
- Respiratory PCR Panels
- Product Type
- Assay Kit
- Technology
- Sample-to-Answer
Application
- Application Area
- Respiratory, Emerging Pathogens
- Target Pathogens
- SARS-CoV-2, Influenza
Regulatory Status
Reported from manufacturer sources and not independently verified.
Buyer Notes
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.
Related Test Guides
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
cobas SARS-CoV-2 & Influenza A/B is intended for use by health professionals or trained operators who are proficient in using the cobas Liat System in Near Patient Testing, Point of Care (POC), or cli
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-04
2026-10-06
availability varies
